Summary
Previous studies have demonstrated that the biovailability of melphalan and chlorambucil may be reduced under non-fasting conditions, and that the gastrointestinal and cellular absorption of melphalan is an active process, while that of chlorambucil is passive. In view of these findings, the effect of dietary amino acids on the gastrointestinal a absorption of these two drugs was investigated using the in situ rat intestine model. The segment lengths used in the study were (mean ±SD) 47.1±3.8 cm. Experimentation was carried out in a randomised fashion and involved monitoring the absorption of drug from control intestinal segments and from segments perfused with L-glycine (1 and 10 mM) and L-leucine (1 and 10 mM). For chlorambucil, absorption was carried out from segments perfused with the 10 mM concentration of amino acids only. Aliquots of gut-perfusing solution were removed at 5-min intervals over 30 min and assayed for drug content using a high-performance liquid chromatography (HPLC) method which was selective for each agent.
Values recorded for the absorption of melphalan were (mean±SD percentage absorption per centimetre segment length over a 30-min period) 1.11%±0.07% cm-1 (control); 1.18%±0.20% cm-1 (1 mM L-glycine); 0.99%±0.27% cm-1 (1 mM L-leucine); 0.80%±0.25% cm-1 (10 mM L-glycine); and 0.60%±0.23% cm-1 (10 mM L-leucine). Chlorambucil absorption from control animals was 1.77%±0.11% cm-1 gut length, as against 1.77%±0.08% cm-1 in 10 mM L-glycine and 1.69%±0.16% cm-1 in 10 mM-L-leucine-perfused segments. The only statistically significant observation was a reduction in melphalan absorption from perfusate containing 10 mM leucine (P<0.005). The experimental data suggest that competitive inhibition by amino acids may be one of the mechanisms involved in the observed reduction in melphalan bioavailability under non-fasting conditions, but that it has no effect on chlorambucil absorption.
Similar content being viewed by others
References
Adair CG, McElnay JC (1986) Studies on the mechanism of gastrointestinal absorption of melphalan and chlorambucil. Cancer Chemother Pharmacol 17: 95
Adair DG, Burns DT, Crockard AD, Desai ZR, Harriott M (1984) Modified extraction and chromatography for the measurement of plasma melphalan by ion pair high performance liquid chromatography. J Chromatogr [Biomed Appl] 336: 429
Adair CG, Burns DT, Crockard AD, Harriott M (1985) Determination of chlorambucil in plasma using reversed phase high performance liquid chromatography. J Chromatogr [Biomed Appl] 342: 447
Adair CG, Bridges JM, Desai ZR (1986) Can food affect the bioavailability of chlorambucil in patients with haematological malignancies? Cancer Chemother Pharmacol 17: 99
Alberts DS, Chang SY, Chen H-SG, Evans TL, Moon TE (1979) Oral melphalan kinetics. Clin Pharmacol Ther 26: 737
Begleiter A, Goldenberg GJ (1983) Uptake and decomposition of chlorambucil by L 5178Y Lymphoblasts in vitro. Biochem Pharmacol 32: 535
Bosanquet AG, Gilby ED (1982) Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma. Eur J Clin Oncol 18: 355
Bosanquet AG, Gilby ED (1984) Comparison of fed and fasting states on the absorption of melphalan in multiple myeloma. Cancer Chemother Pharmacol 12: 183
Chatterji DC, Yeager RL, Gallelli JT (1982) Kinetics of chlorambucil hydrolysis using high pressure liquid chromatography. J Pharm Sci 71: 50
Connors TA (1975) Mechanism of action of 2-chloroethylamine derivatives. In: Sartorelli AC, Johns DG (eds) Hdb Exp Pharm XXXVIII/2. Springer, Berlin Heidelberg New York, pp 18–34
Doluisio JT, Billups NF, Dittert LW, Sugita ET, Swintosky JV (1969) Drug Absorption: I. In situ gut technique yielding realistic absorption rates. J Pharm Sci 58: 1196
Dorr RT, Fritz W (1980) Cancer chemotherapy handbook. Kimpton, London, p 303
Goldenberg GJ, Lee M, Lam HYP, Begleiter A (1977) Evidence for carrier mediated transport of melphalan by L 5178 lymphoblasts in vitro. Cancer Res 37: 755
Goldenberg GJ, Lam HYP, Begleiter A (1979) Active carrier mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasma cytoma cells in vitro. J Biol Chem 254: 1057
Hill BT (1972) Studies on the transport and cellular distribution of chlorambucil in the Yoshida ascites sarcoma. Biochem Pharmacol 21: 495
Kohn KW (1981) Molecular mechanisms of cross-linking by alkylating agents and platinum complexes. In: Sartorelli AC, Lazo JS, Bertino JR (eds) Molecular actions and targets for cancer chemotherapeutic agents. Academic Press, New York, pp 3–16
Leff P, Bardsley WG (1979) Pharmacokinetics of chlorambucil in ovarian carcinoma using a new HPLC assay. Biochem Pharmacol 28: 1289
Swintosky JV, Pogonowska-Wala E (1982) The in situ rat gut technique. A rapid, simple inexpensive way to study factors influencing drug absorption rate from the intestine. Pharm Int 5: 163
Tattersall MHN, Jarman M, Newlands ES, Holyhead L, Milstead RAV, Weinberg A (1978) Pharmacokinetics of mephalan following oral or intravenous administration in patients with malignant disease. Eur J Cancer 14: 507
Vistica DT, Toal JN, Rabinovitz M (1976) Amino acid conferred resistance to melphalan: I. Structure-activity relationship in cultured L1210 leukaemia cells. Cancer Treat Rep 60: 1363
Vistica DT, Toal JN, Rabinovitz M (1977) Amino acids affecting melphalan transport and cytotoxicity in cultured L1210 cells. Pro Am Assoc Cancer Res 18: 26
Vistica DT, Toal JN, Rabinovitz M (1978) Amino acid conferred protection against melphalan: characterisation of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukaemia cells. Biochem Pharmacol 27: 2865
Welling PG (1977) Influence of food and diet on gastrointestinal drug absorption. A Review. J Pharmacol Biopharm 5: 293
Woodhouse KW, Hamilton P, Lennard A, Rawlins MD (1983) The pharmacokinetics of melphalan in patients with multiple myeloma: An intravenous/oral study using conventional dose regimen. Eur J Clin Pharmacol 24: 283
Author information
Authors and Affiliations
Additional information
This work was supported by the Northern Ireland Leukaemia Research Fund
Rights and permissions
About this article
Cite this article
Adair, C.G., McElnay, J.C. The effect of dietary amino acids on the gastrointestinal absorption of melphalan and chlorambucil. Cancer Chemother. Pharmacol. 19, 343–346 (1987). https://doi.org/10.1007/BF00261486
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00261486